Cuprina Holdings (Cayman) Ltd. (CUPR): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Cuprina Holdings Limited (CUPR)

Cuprina Holdings (Cayman) Ltd (CUPR) is expanding its presence in Asia by implementing biomedical therapies for chronic wounds. Business revenues are based on the sale of innovative dressings and biological products derived from larvae. Stable working capital and liquidity ratios support operational activities. Analyzing the price-to-sales ratio, it is evident that the 320.90 mark indicates the current market valuation of the asset.

Cuprina Holdings (Cayman) Ltd. (CUPR): Rasio rega marang pendapatan saka 17.05.2025 nganti 17.11.2026

Cuprina Holdings (Cayman) Ltd (CUPR) - rincian metrik lan laporan keuangan

Analisis umum perusahaan:Cuprina Holdings (Cayman) Ltd., CUPR
Produk mawa merek Cuprina Holdings Limited

To assess the investment attractiveness of Cuprina Holdings (Cayman) Ltd (CUPR), it is essential to determine the fairness of the current market price. The price-to-sales ratio reflects how much an investor pays per unit of revenue, making it possible to identify asset overvaluation. For the science-intensive business of the Singaporean management, this indicator serves as a measure of the efficiency of commercializing innovative treatment methods. Low values minimize the risk of overpaying, although a critical minimum may signal capital stagnation.

Pesaing Cuprina Holdings (Cayman) Ltd

HCA (HCA Healthcare) - Rasio kapitalisasi pasar marang pendapatan|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Fresenius Medical (FMS) - Rega marang dodolan|Solventum Corp - Multiplikator P/S|Rasio rega marang dodolan EHC|Universal Health Services (UHS) - Rasio rega marang pendapatan|DaVita - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RDNT|OPCH: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Rasio kapitalisasi pasar marang pendapatan|National Vision - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Progyny Inc (PGNY)|Ardent Health - Multiplikator P/S|Koefisien rega marang pendapatan Select Medical Corp SEM|ASTH: Multiplikator P/S|Rasio kapitalisasi marang pendapatan MD|USPH (US Physical Therapy Inc) - Multiplikator P/S|PNTG: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rega marang dodolan|EOLS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan MDWD|Rasio rega marang pendapatan biote Corp.|Rega marang dodolan thejoint.com JYNT|Multiplikator P/S DCGO|Kapitalisasi marang pendapatan P3 Health PIII|Multiplikator P/S GANX (Gain Therapeutics Inc.)|Multiplikator P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator P/S|CLGN: Rasio rega marang pendapatan|CCM: Multiplikator P/S|AMS: Kapitalisasi marang volume dodolan|MRM (MEDIROM Corp) - Multiplikator P/S|ALBT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DHAI|Longevity Health Holdings - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Rasio rega marang dodolan|CMAX: Kapitalisasi marang pendapatan|Rega marang dodolan Kindly Health|ModivCare (MODV) - Rasio rega marang pendapatan|NVOS (novointegrated.com) - Rasio rega marang pendapatan|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|BACK (IMAC Holdings Inc) - Kapitalisasi marang volume dodolan